Form 8-K - Current report:
SEC Accession No. 0001689548-25-000056
Filing Date
2025-05-02
Accepted
2025-05-02 08:35:39
Documents
15
Period of Report
2025-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prax-20250502.htm   iXBRL 8-K 32694
2 EX-99.1 praxisq12025pr.htm EX-99.1 72781
6 image_0.jpg GRAPHIC 10958
  Complete submission text file 0001689548-25-000056.txt   259968

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20250502.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20250502_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20250502_pre.xml EX-101.PRE 13054
17 EXTRACTED XBRL INSTANCE DOCUMENT prax-20250502_htm.xml XML 2854
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39620 | Film No.: 25905606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)